54 min
When and How to Get the New COVID Antivirals (with America’s Chief Scientific Officer David Kessler) In the Bubble with Andy Slavitt
-
- News
Andy brings you information directly from the source to let you know what to expect when the antivirals arrive: who will get them, how to get them, when to get yours, and the biggest question — will they change everything? In an exclusive interview with In the Bubble, Dr. David Kessler, Chief Science Officer of the White House COVID-19 Response Team, tells Andy how he is personally navigating Omicron and what the Biden Administration is doing to ensure that we have the capacity to respond quickly to the next pandemic.
Keep up with Andy on Twitter @ASlavitt and Instagram @andyslavitt.
Follow David @DavidAKesslerMD on Twitter.
Joining Lemonada Premium is a great way to support our show and get bonus content. Subscribe today at bit.ly/lemonadapremium.
Support the show by checking out our sponsors!
Click this link for a list of current sponsors and discount codes for this show and all Lemonada shows: https://lemonadamedia.com/sponsors/
Throughout the pandemic, CVS Health has been there, bringing quality, affordable health care closer to home—so it’s never out of reach for anyone. Because at CVS Health, healthier happens together. Learn more at cvshealth.com.
Check out these resources from today’s episode:
Learn more about the NIH’s COVID-19 treatment guidelines: https://www.covid19treatmentguidelines.nih.gov/
Check out the New England Journal of Medicine article on Remdesivir that David mentions in today’s episode: https://www.nejm.org/doi/full/10.1056/NEJMoa2116846
Find a COVID-19 vaccine site near you: https://www.vaccines.gov/
Order Andy’s book, Preventable: The Inside Story of How Leadership Failures, Politics, and Selfishness Doomed the U.S. Coronavirus Response: https://us.macmillan.com/books/9781250770165
Stay up to date with us on Twitter, Facebook, and Instagram at @LemonadaMedia.
For additional resources, information, and a transcript of the episode, visit lemonadamedia.com/show/inthebubble.
See omnystudio.com/listener for privacy information.
Andy brings you information directly from the source to let you know what to expect when the antivirals arrive: who will get them, how to get them, when to get yours, and the biggest question — will they change everything? In an exclusive interview with In the Bubble, Dr. David Kessler, Chief Science Officer of the White House COVID-19 Response Team, tells Andy how he is personally navigating Omicron and what the Biden Administration is doing to ensure that we have the capacity to respond quickly to the next pandemic.
Keep up with Andy on Twitter @ASlavitt and Instagram @andyslavitt.
Follow David @DavidAKesslerMD on Twitter.
Joining Lemonada Premium is a great way to support our show and get bonus content. Subscribe today at bit.ly/lemonadapremium.
Support the show by checking out our sponsors!
Click this link for a list of current sponsors and discount codes for this show and all Lemonada shows: https://lemonadamedia.com/sponsors/
Throughout the pandemic, CVS Health has been there, bringing quality, affordable health care closer to home—so it’s never out of reach for anyone. Because at CVS Health, healthier happens together. Learn more at cvshealth.com.
Check out these resources from today’s episode:
Learn more about the NIH’s COVID-19 treatment guidelines: https://www.covid19treatmentguidelines.nih.gov/
Check out the New England Journal of Medicine article on Remdesivir that David mentions in today’s episode: https://www.nejm.org/doi/full/10.1056/NEJMoa2116846
Find a COVID-19 vaccine site near you: https://www.vaccines.gov/
Order Andy’s book, Preventable: The Inside Story of How Leadership Failures, Politics, and Selfishness Doomed the U.S. Coronavirus Response: https://us.macmillan.com/books/9781250770165
Stay up to date with us on Twitter, Facebook, and Instagram at @LemonadaMedia.
For additional resources, information, and a transcript of the episode, visit lemonadamedia.com/show/inthebubble.
See omnystudio.com/listener for privacy information.
54 min